Virtual Reality on Pain, Stress, and Affect in the Infusion Clinic

Cody Stansel99 enrolled

Overview

This study will investigate the ability of virtual reality to function as a novel distraction intervention and improve the experience of patients who are receiving chemotherapy in the infusion clinic.

Objectives: Primary Objective: \- To deploy and evaluate virtual reality as an intervention for stress, pain, and negative affect Secondary Objective: \- To evaluate cyber sickness and patient satisfaction related to the virtual reality treatment

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

SUPPORTIVE_CARE

Masking

SINGLE

Enrollment

Conditions

Cancer Chemotherapy

Interventions

Virtual reality therapyBEHAVIORAL

Participants will watch a video allowing them to view nature, dinosaurs, animals, and human interactions in three dimensions during a session lasting 11 minutes.

QuestionnairesBEHAVIORAL

Questionnaires will be completed regarding stress, pain and affect

Measure heart ratePROCEDURE

To be measured prior to starting treatment and halfway through the 11 minute Video

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * At or above the age of 18 * English Speaking * Diagnosed with cancer * No previous history of seizures, losses of awareness, or other symptoms linked to an epileptic condition * Not sensitive to motion sickness * Not currently experiencing any contagious conditions, infections, or diseases (particularly of the eyes, skin, or scalp) * Does not use a device to regulate heart rate or rhythm (such as a pacemaker) * Not taking antiarrhythmic medications * Not actively receiving radiopharmaceutical therapy Exclusion: * To ensure that there is sufficient time to complete the virtual reality treatment, patients who are scheduled for visits for periods of less than one hour will not be included in this study. Additionally, patients must consent to participating in the study on the day of the experience. * Patients who are asleep prior to consenting will not be asked to participate in the study

Locations (1)

Vanderbilt-Ingram Cancer Center

Nashville, Tennessee, United States

Outcomes

Primary Outcomes

Positive or negative effect of Virtual Reality therapy on improving the experience of participants receiving chemotherapy

Measured by the Positive and Negative Affect Scale (0=minimum to 5=maximum). Consisting of a number of words that describe different feelings and emotions. Patients are instructed to indicate to what extent they currently feel each of the feelings or emotions. Afterwards, patient responses are scored to produce a numerical positive affect score and a negative affect score.

Time frame: Approximately 12 months

Measure the affect of Virtual Reality Therapy on improving stress

Measured by stress level using the stress numerical rating

Time frame: Approximately 12 months

Measure the affect of Virtual Reality Therapy on improving pain

Measured by pain level using the pain numerical score (scale 0 (none) to 10 (worst)

Time frame: Approximately 12 months

Secondary Outcomes

Rate of cyber sickness (Virtual Reality Therapy Arm Only)

Measured with the Fast MS Scale (FMS), a verbal rating scale ranging from zero (no sickness at all) to 20 (frank sickness).

Time frame: Approximately 12 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.